Details for New Drug Application (NDA): 204229
✉ Email this page to a colleague
The generic ingredient in ZOLPIDEM TARTRATE is zolpidem tartrate. There are thirty-three drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the zolpidem tartrate profile page.
Summary for 204229
Tradename: | ZOLPIDEM TARTRATE |
Applicant: | Endo Operations |
Ingredient: | zolpidem tartrate |
Patents: | 0 |
Pharmacology for NDA: 204229
Mechanism of Action | GABA A Receptor Positive Modulators |
Physiological Effect | Central Nervous System Depression |
Suppliers and Packaging for NDA: 204229
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ZOLPIDEM TARTRATE | zolpidem tartrate | TABLET;SUBLINGUAL | 204229 | ANDA | ENDO USA, Inc. | 49884-898 | 49884-898-11 | 30 POUCH in 1 CARTON (49884-898-11) / 1 TABLET in 1 POUCH (49884-898-52) |
ZOLPIDEM TARTRATE | zolpidem tartrate | TABLET;SUBLINGUAL | 204229 | ANDA | ENDO USA, Inc. | 49884-899 | 49884-899-11 | 30 POUCH in 1 CARTON (49884-899-11) / 1 TABLET in 1 POUCH (49884-899-52) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;SUBLINGUAL | Strength | 1.75MG | ||||
Approval Date: | Sep 11, 2017 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;SUBLINGUAL | Strength | 3.5MG | ||||
Approval Date: | Sep 11, 2017 | TE: | AB | RLD: | No |
Complete Access Available with Subscription